<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: University of Utah Health Sciences in the news</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress provides the latest news from University of Utah Health Sciences</description>

 <item>
     <title>Long-suspected cause of blindness from eye disease disproved</title>
   	 <description>Vision scientists long have thought that lack of very long chain fatty acids in photoreceptor cells caused blindness in children with Stargardt type 3 retinal degeneration, an incurable eye disease. But researchers at the University of Utah's John A. Moran Eye Center have shown in a new study that lack of these fatty acids does not cause blindness, meaning that the search for the mechanism that robs sight from children with the disease must start anew.</description>
     <link>http://medicalxpress.com/news/2013-03-long-suspected-eye-disease.html</link>
	 <category>Ophthalmology</category>
	 <pubDate>Mon, 11 Mar 2013 17:02:40 EST</pubDate>
	 <guid isPermaLink="false">news282240153</guid>
	 
</item>
<item>
     <title>Mouse model improves understanding of clear cell sarcoma</title>
   	 <description>Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form.</description>
     <link>http://medicalxpress.com/news/2013-02-mouse-cell-sarcoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 11 Feb 2013 12:00:04 EST</pubDate>
	 <guid isPermaLink="false">news279802041</guid>
	 
</item>
<item>
     <title>Statin drug shows promise for fighting malaria effects</title>
   	 <description>Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to traditional antimalarial treatment decreases neuroinflammation and protects against cognitive impairment in a mouse model of cerebral malaria. Although there are differences between mouse models of cerebral malaria and human disease, these new findings indicate that statins are worthy of consideration in clinical trials of cerebral malaria, according to an article published in the Dec. 27 issue of PLOS Pathogens.</description>
     <link>http://medicalxpress.com/news/2012-12-statin-drug-malaria-effects.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 27 Dec 2012 17:00:03 EST</pubDate>
	 <guid isPermaLink="false">news275848796</guid>
	 
</item>
<item>
     <title>Drug to treat opioid addiction poses risks for accidental exposure to children</title>
   	 <description>Buprenorphine is a safe and effective drug for treating opioid addiction. But as the prescribed use of buprenorphine has dramatically increased in recent years, accidental exposure of children to the drug has risen sharply, placing them at risk for serious injury and in extremely rare cases even death, according to researchers at the Utah Poison Control Center (UPCC), U School of Medicine's Department of Family and Preventive Health, and the Utah Department of Health (UDOH).</description>
     <link>http://medicalxpress.com/news/2012-12-drug-opioid-addiction-poses-accidental.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 14 Dec 2012 15:30:29 EST</pubDate>
	 <guid isPermaLink="false">news274721415</guid>
	 
</item>
<item>
     <title>Rural dwellers less likely to follow cancer screening guidelines</title>
   	 <description>People who reside in rural areas of Utah are less likely to follow colorectal cancer (CRC) screening recommendations than their urban counterparts, according to researchers from Huntsman Cancer Institute (HCI) at the University of Utah. This geographic disparity is evident across all risk groups, including those who have a family history of the disease.</description>
     <link>http://medicalxpress.com/news/2012-12-rural-dwellers-cancer-screening-guidelines.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 14 Dec 2012 09:54:19 EST</pubDate>
	 <guid isPermaLink="false">news274701254</guid>
	 
</item>
<item>
     <title>Clinical trial delivers good results in leukemia patients</title>
   	 <description>Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard treatments for chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic lymphoma (Ph+ ALL). The New England Journal of Medicine released results of the trial today.</description>
     <link>http://medicalxpress.com/news/2012-11-clinical-trial-good-results-leukemia.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 30 Nov 2012 09:10:17 EST</pubDate>
	 <guid isPermaLink="false">news273489005</guid>
	 
</item>
<item>
     <title>Possible new treatment for Ewing sarcoma</title>
   	 <description>Discovery of a new drug with high potential to treat Ewing sarcoma, an often deadly cancer of children and young adults, and the previously unknown mechanism behind it, come hand-in-hand in a new study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah. The report appears in today's online issue of the journal Oncogene.</description>
     <link>http://medicalxpress.com/news/2012-11-treatment-ewing-sarcoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Nov 2012 13:49:26 EST</pubDate>
	 <guid isPermaLink="false">news273160157</guid>
	 
</item>
<item>
     <title>DNA packaging discovery reveals principles by which CRC mutations may cause cancer</title>
   	 <description>A new discovery from researchers at Huntsman Cancer Institute (HCI) at the University of Utah concerning a fundamental understanding about how DNA works will produce a &quot;180-degree change in focus&quot; for researchers who study how gene packaging regulates gene activity, including genes that cause cancer and other diseases. The discovery, by Bradley R. Cairns, PhD, Senior Director of Basic Science at HCI and a professor in the Department of Oncological Sciences, is reported in this week's online issue of the journal Nature.</description>
     <link>http://medicalxpress.com/news/2012-11-dna-packaging-discovery-reveals-principles.html</link>
	 <category>Genetics</category>
	 <pubDate>Fri, 16 Nov 2012 19:35:15 EST</pubDate>
	 <guid isPermaLink="false">news272316905</guid>
	 
</item>
<item>
     <title>Discovery shows medications can treat inflammation without increasing risk for infection</title>
   	 <description>In a discovery that can fundamentally change how drugs for arthritis, and potentially many other diseases, are made, University of Utah medical researchers have identified a way to treat inflammation while potentially minimizing a serious side effect of current medications: the increased risk for infection.</description>
     <link>http://medicalxpress.com/news/2012-11-discovery-medications-inflammation-infection.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Sun, 11 Nov 2012 13:00:44 EST</pubDate>
	 <guid isPermaLink="false">news271860828</guid>
	 
</item>
<item>
     <title>Genetic test results for Lynch syndrome improved with new computer program</title>
   	 <description>Many patients who have genetic testing for Lynch syndrome, a hereditary predisposition to colon cancer, receive the inconclusive result &quot;variants of uncertain clinical significance.&quot; This can be a problem, as people with Lynch syndrome have a much higher probability to develop colon cancer, and often develop colon cancer at an earlier age than is common among the general population; consequently, they need to begin screening at a much younger age.</description>
     <link>http://medicalxpress.com/news/2012-11-genetic-results-lynch-syndrome.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 01 Nov 2012 13:36:24 EST</pubDate>
	 <guid isPermaLink="false">news270995773</guid>
	 
</item>
<item>
     <title>Wnt signaling pathway plays key role in adult nerve cell generation: study</title>
   	 <description>Researchers from the University of Utah have gained new insight into the regulation of adult nerve cell generation in the hypothalamus, the part of the brain that regulates many aspects of behavior, mood, and metabolism. In the Sept. 10, 2012, issue of Developmental Cell they report that a cell-to-cell communication network known as the Wnt signaling pathway plays an important role in both the production and specialization of nerve cell precursors in the hypothalamus.</description>
     <link>http://medicalxpress.com/news/2012-09-wnt-pathway-key-role-adult.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 10 Sep 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news266491163</guid>
	 
</item>
<item>
     <title>HIF gene mutation found in tumor cells offers new clues about cancer metabolism</title>
   	 <description>For the first time, a mutation in HIF2α, a specific group of genes known as transcription factors that is involved in red blood cell production and cell metabolism, has been identified in cancer tumor cells.</description>
     <link>http://medicalxpress.com/news/2012-09-hif-gene-mutation-tumor-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 06 Sep 2012 10:05:04 EST</pubDate>
	 <guid isPermaLink="false">news266144696</guid>
	 
</item>
<item>
     <title>Molecular 'movies' may accelerate anti-cancer drug discovery</title>
   	 <description>Using advanced computer simulations, University of Utah College of Pharmacy researchers have produced moving images of a protein complex that is an important target for anti-cancer drugs. This advancement has significant implications for discovering new therapies that could attack cancer without damaging the DNA of healthy cells, according to an article published July 31, 2012 in the Proceedings of the National Academy of Sciences.</description>
     <link>http://medicalxpress.com/news/2012-08-molecular-movies-anti-cancer-drug-discovery.html</link>
	 <category>Genetics</category>
	 <pubDate>Fri, 17 Aug 2012 09:20:03 EST</pubDate>
	 <guid isPermaLink="false">news264413053</guid>
	 
</item>
<item>
     <title>Genomic study of rare children's cancer yields possible prognostic tool</title>
   	 <description>A new study of the genetic makeup, or genome, of Ewing sarcoma, a rare cancer that strikes children, teenagers, and young adults, has produced multiple discoveries: a previously unknown sarcoma subtype, genetic factors related to long-term survival, and identification of a genetic change between the primary and metastatic stages of the disease that could lead to better, more targeted treatment.</description>
     <link>http://medicalxpress.com/news/2012-08-genomic-rare-children-cancer-yields.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Aug 2012 09:26:20 EST</pubDate>
	 <guid isPermaLink="false">news263723174</guid>
	 
</item>
<item>
     <title>Creatine aids women in outmuscling major depression</title>
   	 <description>Women battling stubborn major depression may have a surprising new ally in their fight&amp;#151;the muscle-building dietary supplement creatine.</description>
     <link>http://medicalxpress.com/news/2012-08-creatine-aids-women-outmuscling-major.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Mon, 06 Aug 2012 13:12:57 EST</pubDate>
	 <guid isPermaLink="false">news263477559</guid>
	 
</item>


</channel>
</rss>
